ANNEXON, INC. (ANNX)
Clinical trial NCT04514367 updates: 1. start date: 2020-08-17 → 2020-09-29 2. completion date: 2022-01-28 → 2022-08-29 3. primary completion date: 2022-01-28 → 2022-08-29
Clinical trial NCT04514367 updates: 1. start date: 2020-08-17 → 2020-09-29 2. completion date: 2022-01-28 → 2022-08-29 3. primary completion date: 2022-01-28 → 2022-08-29
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical